Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleArticles

The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer

NASIM SALIMIAGHDAM, XUEBIN YANG and HONGYAN LIANG
Anticancer Research May 2026, 46 (5) 2915-2923; DOI: https://doi.org/10.21873/anticanres.18169
NASIM SALIMIAGHDAM
1Internal Medicine Department, Capital Health Regional Medical Center, Trenton, NJ, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nsalimiaghdam{at}capitalhealth.org
XUEBIN YANG
2Department of Pathology, Capital Health Regional Medical Center, Trenton, NJ, U.S.A.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HONGYAN LIANG
3Department of Hemato-Oncology, Capital Health Regional Medical Center, Trenton, NJ, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Ovarian metastases from colorectal carcinoma (CRC) are rare but have significant clinical implications, often resembling primary ovarian tumors. An incorrect diagnosis can result in delayed systemic therapy and surgical planning.

Case Report: A 56-year-old postmenopausal woman presented with right lower quadrant pain and postmenopausal bleeding. Pelvic ultrasound and computed tomography (CT) scans demonstrated a large, complex adnexal mass with thickening of the ascending colonic wall. She underwent diagnostic laparoscopy and subsequent total abdominal hysterectomy with bilateral salpingo-oophorectomy, omentectomy, tumor debulking, and right hemicolectomy. The postoperative pathology revealed a moderately differentiated adenocarcinoma of the cecum, with bilaterally metastatic involvement of the ovaries, omentum, peritoneal surfaces, and liver serosa. Immunohistochemistry confirmed the colonic origin (CDX2+, CK20+, CK7−). She was diagnosed with stage IVc (pT4aN2aM1c) colon adenocarcinoma and subsequently started on systemic treatment with mFOLFIRINOX with bevacizumab.

Conclusion: This case highlights the diagnostic challenge of distinguishing between primary ovarian carcinoma and metastatic colorectal adenocarcinoma, underscoring the need for multidisciplinary collaboration and immunohistochemical confirmation to inform treatment decisions.

Keywords:
  • Colorectal cancer
  • ovarian metastasis
  • Krukenberg tumor
  • CDX2
  • immunohistochemistry
  • right-sided colon cancer
  • metastatic adenocarcinoma
  • mFOLFIRINOX
  • bevacizumab
  • adnexal mass
  • peritoneal metastasis
  • Received February 2, 2026.
  • Revision received February 24, 2026.
  • Accepted February 26, 2026.
  • Copyright © 2026 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 46 (5)
Anticancer Research
Vol. 46, Issue 5
May 2026
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer
NASIM SALIMIAGHDAM, XUEBIN YANG, HONGYAN LIANG
Anticancer Research May 2026, 46 (5) 2915-2923; DOI: 10.21873/anticanres.18169

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
The Ovarian Portal: An Unusual Pathway to Discovery, A Rare Initial Manifestation of Colon Cancer
NASIM SALIMIAGHDAM, XUEBIN YANG, HONGYAN LIANG
Anticancer Research May 2026, 46 (5) 2915-2923; DOI: 10.21873/anticanres.18169
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Case Report
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Risk Factors for Niraparib-induced Severe Anemia in Japanese Patients With Ovarian Cancer: A Multicenter Study
  • Ovarian Sertoli Cell Tumor Coexisting With Uterine Malformation: A Case Report
  • Ascites: A Potential Diagnostic Surrogate for Genetic Profiling in Ovarian Cancer
Show more Articles

Keywords

  • colorectal cancer
  • ovarian metastasis
  • Krukenberg tumor
  • CDX2
  • immunohistochemistry
  • right-sided colon cancer
  • metastatic adenocarcinoma
  • mFOLFIRINOX
  • bevacizumab
  • adnexal mass
  • peritoneal metastasis
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire